Connection

Diane Descamps to Raltegravir Potassium

Back to Details
This is a "connection" page, showing publications Diane Descamps has written about Raltegravir Potassium.
Diane Descamps
Connection Strength
0.239
Raltegravir Potassium
  1. First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). Clin Infect Dis. 2018 09 28; 67(8):1161-1167.
    View in: PubMed
    Score: 0.175
  2. HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors. J Antimicrob Chemother. 2017 09 01; 72(9):2431-2437.
    View in: PubMed
    Score: 0.041
  3. High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial. Clin Infect Dis. 2009 Nov 01; 49(9):1441-9.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.